Interventional Pulmonology Program

Interventional Pulmonology ProgramThe National Jewish Health Interventional Pulmonology Program offers a wide spectrum of minimally invasive diagnostic, therapeutic and palliative (symptom-relieving) airway procedures.

National Jewish Health is now one of only a handful of centers around the country-and the only center in the Rocky Mountain Region-offering interventional pulmonology services with a formally trained specialist. 

Ali Musani, MD, FCCP, joined National Jewish Health to create our Interventional Pulmonology Program. Dr. Musani is an international expert in the latest technologies, such as Endobronchial Ultrasound System for early detection and staging of cancers of the lung and other organs, superDimension Navigation System for early diagnosis of pulmonary nodules, laser therapy to destroy tumors, and stent placement in the airways for many benign and malignant diseases. He is also considered a national and international leader in the use of long term indwelling pleural catheters for the treatment of malignant pleural effusions.

 

Our Services

  • Identify, diagnose and treat pulmonary nodules

  • Early detection of lung cancer

  • Diagnose and treat airway obstructions due to benign and malignant diseases

  • Airway recanalization with laser and other modalities

  • Removal of foreign bodies

  • Pleural procedures 

  • Airways stent implantation and removal

  • Balloon bronchoplasty

Procedure Units

The Interventional Pulmonology team will perform most procedures at National Jewish Health, however, procedures requiring anesthesia, an operating room or follow-up ICU care will be done at Rose Medical Center. 

Our procedure units are equipped with:

 

Clinical Trials

The Interventional Pulmonology team will be conducting several multinational and national clinical trials, including those focused on treatment of asthma and emphysema with non-pharmacological approaches.

Featured Research

Genome Study Suggests New Strategies for Understanding and Treating Pulmonary Fibrosis

In findings published online in Nature Genetics on April 14, 2013, researchers at National Jewish Health, the University of Colorado and several other institutions found a number of genes associated with host defense, cell-cell adhesion and DNA repair, which provide clues to possible mechanisms underlying this currently untreatable disease. Read more.

Faculty by Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our Faculty by Area of Research.